Efficacy and Safety Evaluation of the Imescard Compound Water Smartweed Ointment

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The aim of our study was to assess the clinical efficacy and safety of the drug Imescard compound water smartweed, adrenalin and hamamelis ointment in the treatment of hemorrhoidal disease in adults, in a randomized, double-blind, placebo-controlled clinical trial.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Hospital de Clinicas de Porto Alegre

Criteria

Inclusion Criteria:

• Age between 18 and 70 years old

• 2nd to 4th degree hemorrhoids clinically diagnosed

• Proper anticonception, in the case of women in fertile age

• Possibility to abstain from any other drugs (except in emergencies, in wich case the responsible party must be informed)

• Good understanding and agreement to informed consent form

Exclusion Criteria:

• Hypersensitivity to any of the components of the drug

• Use of alcohol or drugs

• Clinical evidence of immunosupression

• Abnormalities in baseline laboratory exams

• Diagnosis of any acute disease in current activity or chronic disease uncontrolled